Covered recipient · General Payments record
JAMES RYAN MILLER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2025
$554.69
- Reported across 20 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $508.58 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $289.62 | 13 |
| Madrigal Pharmaceuticals | $149.99 | 1 |
| Novo Nordisk AS | $37.53 | 2 |
| Esperion Therapeutics, Inc. | $31.44 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | $15.53 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243968434 | CMS |
| Esperion Therapeutics, Inc. | $15.91 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243968436 | CMS |
| Lilly USA, LLC | $20.54 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186744057 | CMS |
| Lilly USA, LLC | $13.20 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186672017 | CMS |
| Lilly USA, LLC | $11.95 | 04/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186693279 | CMS |
| Lilly USA, LLC | $21.56 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186733415 | CMS |
| Lilly USA, LLC | $15.00 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186693285 | CMS |
| Lilly USA, LLC | $114.51 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186693281 | CMS |
| Lilly USA, LLC | $8.81 | 05/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186662995 | CMS |
| Lilly USA, LLC | $19.00 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186693283 | CMS |
| Lilly USA, LLC | $9.82 | 07/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186733411 | CMS |
| Lilly USA, LLC | $11.01 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186672019 | CMS |
| Lilly USA, LLC | $14.40 | 08/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186733413 | CMS |
| Lilly USA, LLC | $18.92 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186744059 | CMS |
| Lilly USA, LLC | $10.90 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186733417 | CMS |
| Madrigal Pharmaceuticals | $149.99 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248289325 | CMS |
| Novo Nordisk Inc | $19.98 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188972847 | CMS |
| Novo Nordisk Inc | $17.55 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188580166 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2022 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.